Related Experiment Video
Updated: Jul 16, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Is valproate encephalopathy under-recognised in older people? A case series
Stefan Beyenburg1, Claude Back, Nico Diederich
1Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. beyenburg.stefan@chl.lu
Background:
Valproate (VPA) is an antiepileptic drug with a broad spectrum of efficacy. Although usually well-tolerated, it may have side-effects of which encephalopathy is one of the most serious.
Objective:
To describe the clinical characteristics of valproate encephalopathy (VE) in five older patients with remote symptomatic seizures treated with rapid VPA loading.
Design:
Case series.
Setting:
Teaching hospital
Patients:
Five patients (71-89 years old) with underlying cerebrovascular disease or dementia and symptomatic seizures.
Results:
VE was characterised by decline in conscious level and (in some cases) increase in seizure frequency. Three of the five patients had elevated ammonia levels. EEG showed generalised slow activity, in some cases accompanied by additional epileptic discharges. The condition was reversible in four patients after VPA discontinuation. One patient died.
Conclusions:
Older people may be at particular risk of VE because of co-morbid pathology, age-related metabolic changes and co-medication.
Related Concept Videos
Hepatic Encephalopathy
Pharmacodynamics in Geriatric Patients: Effects of Age
Encephalitis l: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion